| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $533.7M | — | +2.9% |
| Cost of Revenue | $449.3M | — | +3.4% |
| Gross Profit | $84.4M | — | +0.5% |
| R&D Expense | $8.5M | — | +11.8% |
| SG&A Expense | $49.0M | — | +0.8% |
| Operating Income | $11.4M | — | -11.6% |
| Pre-tax Income | $4.2M | — | -14.3% |
| Income Tax | $19.2M | — | +159.5% |
| Net Income | -$17.9M | — | -258.0% |
| EPS (Basic) | -$0.40 | — | -263.6% |
| EPS (Diluted) | -$0.40 | — | -263.6% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $323.5M | +3.8% | +1.9% |
| Accounts Receivable | $232.8M | +11.5% | +6.8% |
| Inventory | $481.9M | +23.3% | +28.6% |
| Current Assets | $1.10B | +14.4% | +15.8% |
| Total Assets | $1.86B | +7.3% | -1.9% |
| Current Liabilities | $357.5M |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.3M | — | -218.1% |
| Capital Expenditures | $9.6M | — | -22.6% |
| Investing Cash Flow | -$9.5M | — | +23.4% |
| Financing Cash Flow | $57.6M | — | +572.1% |
| Free Cash Flow | -$42.9M | — | -371.5% |
| +14.1% |
| Long-term Debt | $601.9M | +25.0% | — |
| Total Liabilities | $1.15B | +22.0% | +20.8% |
| Stockholders' Equity | $627.9M | -11.7% | -28.0% |